Dr Swati Midha
University College London
3D Bioprinting, Stem cells, biomaterials, animal surgeries, musculoskeletal research
Despite high relevance, musculoskeletal conditions (like osteoarthritis) lack pharmacological treatment due to suboptimal disease models. The organ-on-a-chip technology is a promising alternative to the conventional 2D/3D cell culture models, with closer resemblance to the dynamic in vivo conditions. Hence disease models developed using this technology will reveal important insights about the etiology and severity of diseases and the cellular cross-talks between the different tissues involved in the development of complex musculoskeletal regions, critical for discovering new drug targets and screening of novel drugs for clinical application.